Structural diversity of monoclonal CD4 antibodies and their capacity to block the HIV GP120/CD4 interaction

Hybridoma

Volumn 15, Issue 2, 1996, Pages 117-124

  Weissenhorn, Winfried ^a,b   Chen, Ying Hua ^a   Reiter, Christian ^a   Federle, Christine ^a   Weiss, Elisabeth H ^a   Riethmüller, Gert ^a   Rieber, Ernst P ^a,c  

^a Institut für Immunologie   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Institut für Immunologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; MESSENGER RNA; NUCLEOTIDE; OKT 4;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CROSS REACTION; GENE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

EID: 0029984590     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.117     Document Type: Article

References (57)

1. Tonegawa S: Somatic generation of antibody diversity. Nature (London) 1983;302:575-581.
2. Brodeur P, and Riblet R: The immunoglobulin heavy chain variable region locus in the mouse, one hundred Igh-V genes comprise seven families of homologous genes. Eur J Immunol 1984; 14:922-930.
3. Winter E, Radbruch A, and Krawinkel U: Members of novel VH families are found in VDJ regions of polyclonally activated B lymphocytes. EMBO J 1985;4:2861-2867.
4. Kabat EA, Wu T.T., Reid-Müller M, Perry HM, and Gottesmann KS: Sequences of Proteins of Immunological Interest, 4th ed. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, 1987.
5. Kofler R, Duchosal MA, and Dixon FJ: Complexity, polymorphism, and connectivity of mouse Vk gene families. Immunogenetics 1989;29:65-74.
6. Strohal R, Helmberg A, Kroemer G, and Kofler R: Mouse Vk gene classification by nucleic acid sequence similarity. Immunogenetics 1989;30:475-493.
7. Caton AJ, Brownlee GG, Staudt LM, and Gerhard W: Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. EMBO J 1986;5:1577-1587.
8. Kaartinen M, Griffith GM, Markham AF, and Milstein C: mRNA sequences define an unusually restricted IgG response to 2-phenyl-oxazolone and its early diversification. Nature (London) 1983;304:320-324.
9. Berek C, and Milstein C: Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev 1987;96:23-41.
10. Panka DJ, and Margolies MN: Complete variable region sequences of five homologous high affinity anti-digoxin antibodies. J Immunol 1987;139:2385-2391.
11. Sherman MA, Deans RJ, and Bolger MD: Haioperidol binding to monoclonal antibodies. Hypervariable region amino acid sequence determination. J Biol Chem 1988;263:4059-4063.
12. Schmitter D, Poch O, Zeder G, Heinrich GF, Kocher HP, Quesniaux VFJ, and van Regenmortel MHV: Analysis of the structural diversity of monoclonal antibodies to cyclosporine. Mol Immunol 1990;27:1029-1038.
13. Adderson EE, Shackelford PG, Quinn A, and Carroll WL: Restricted IgH chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol 1991;147:1667-1674.
14. Reinherz EL, Kung PC, Goldstein G, and Schlossman SF: Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 1979;76:4061-4065.
15. Reinherz EL, and Schlossman SF: The differentiation and function of human T lymphocytes. Cell 1980;19:821-827.
16. Stewart SJ, Fujimoto J, and Levy R: Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. J Immunol 1986;136:3773-3778.
17. Maddon PJ, Molineaux SM, Maddon DE, Zimmerman KA, Godfrey M, Alt FW, Chess L, and Axel R: Structure and expression of the human and mouse T4 genes. Proc Natl Acad Sci USA 1987;84:9155-9159.
18. Janeway CA Jr, Carding S, Jones B, Murray J, Portoles P, Rasmussen R, Rojo J, Saizawa K, Wast J, and Bottomly K: CD4+ T cells: Specificity and function. Immunol Rev 1988;101: 39-80.
19. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
20. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, and Montagnier L: T lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 1984;312:767-768.
21. Landau NR, Warton M, and Littman DR: The envelope glycoprotein of the human immunodeficiency viruses HIV-1 and HIV-2 and SIV interact with similar epitopes on their cellular receptors, the CD4 molecule. Nature (London) 1988;334:159-162.
22. Richardson NE, Brown NR, Hussey RE, Vaid A, Matthews TJ, Bolognesi DP, and Reinherz EL: Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. Proc Natl Acad Sci USA 1988;85:6102-6106.
23. Arthos JK, Deen C, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, Axel R, Truneh A, Maddon PJ, and Sweet RW: Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-481.
24. Lindenmann J: Speculations on idiotypes and homobodies. Ann Immunol (Paris) 1973;124:171-184.
25. Jerne NK: Towards a network theory of the immune systems. Ann Immunol (Paris) 1974;125:373-389.
26. Peterson A, and Seed B: Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72.
27. Sattentau QJ, Arthos J, Deen K, Hanna N, Healey D, Beverly PCL, Sweet R, and Truneh A: Structural analysis of the human immunodeficiency virus binding domain of CD4. J Exp Med 1988; 170:1319-1334.
28. Ashkenazi A, Presta LG, Marsters SA, Camerato TR, Rosenthal KA, Fendly BM, and Capon DJ: Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci USA 1990;87:7150-7154.
29. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai X, Xuong N, Axel R, Sweet RW, and Hendrickson WA: Crystal structure of an HIV binding recombinant fragment of human CD4. Nature (London) 1990;348:419-425.
30. Wang J, Yan Y, Garrett TPJ, Liu J, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, and Harrison ST: Atomic structure of a fragment of human CD4 containing two immunoglobulin like domains. Nature (London) 1990;348:411-418.
31. Camerini D, and Seed B: A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 1990;60:747-754.
32. Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, and Devaux C: Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol 1993;150:290-301.
33. Broder CC, and Berger EA: CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein mediated cell fusion. J Virol 1993;67:913-926.
34. Prinz JC, and Rieber EP: Fc-receptors for IgE on human lymphocytes. Detection with a rosetting assay using a recombinant hu-man/mouse IgE antibody and characterization with monoclonal antibodies. Hybridoma 1987;6:1-16.
35. Chirgwin JM, Przybyla AE, MacDonald AJ, and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
36. Maxam AM, and Gilbert W: A new method for sequencing DNA. Proc Natl Acad Sci USA 1977;74:560-564.
37. Kurosawa Y, and Tonegawa S: Organization, structure and assembly of immunoglobulin heavy chain diversity DNA segments. J Exp Med 1982;155:201-218.
38. Alt F, and Baltimore D: Joining of immunoglobulin heavy chain segments: Implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci USA 1982;79: 4118-4122.
39. Caton AJ, Stark S, Kavaler J, Staudt LM, Schwartz D, and Gerhard W: Many variable region genes are utilized in the antibody response of BALB/c mice to the influenza virus A/PR/8/34 hemagglutinin. J Immunol 1991;147:1675-1686.
40. Wang D, Liao J, Mitra D, Akolkar PN, Gruezo F, and Kabat EA: The repertoire of antibodies to a single antigenic determinant. Mol Immunol 1991;28:1387-1397.
41. Lohman KL, Attanasio R, Buck D, Carrillo MA, Allan JS, and Kennedy RC: Characteristics of murine monoclonal anti-CD4. J Immunol 1992;149:3247-3253.
42. Smith-Gill SJ, Hamel PA, Lovoie ThB, and Dorrington KJ: Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens. J Immunol 1987;139:4135-4144.
43. Tainer JA, Deal CD, Geysen MH, Roberts VA, and Getzoff ED: Defining antibody-antigen recognition: Towards engineered antibodies and epitiopes. Int Rev Immunol 1991;7:165-188.
44. Kabat EA, and Wu TT: Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. J Immunol 1991;147:1709-1719.
45. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sarhe G, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietro-Paolo C, Axel R, Truneh A, Maddon PJ, and Sweet RW: Identification of residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-481.
46. Brodsky MH, Warton M, Myers RM, and Littman DR: Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 1990;144:3078-3086.
47. Capon DJ, and Ward RHR: The CD4-gp120 interaction and AIDS pathogenesis. Annu Rev Immunol 1991;9:649-678.
48. Lasky L, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987; 50:975-985.
49. Truneh A, Buck D, Cassatt DR, Juszczak R, Kassis S, Ryu SE, Healey D, Sweet R, and Sattentau Q: A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem 1991;266: 5942-5948.
50. H related idiotopes detected by site-directed mutagenesis: A study induced by the failure to find CD4 anti-idiotypic antibodies mimicking the cellular receptor of HIV. J Immunol 1992;149:1237-1241.
51. Dalgleish AG, Thomson BJ, Chanh TC, Malkovsky M, and Kennedy RC: Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: A potential aids vaccine. Lancet 1987;II:1047-1050.
52. Davies SJ, Schockmel GA, Somoza C, Buck DW, Healey DG, Rieber EP, Reiter C, and Williams A: Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (London) 1992;358:76-79.
53. Sutor GC, Dreikhausen U, Vahning U, Jurkiewicz E, Hunsmann G, Lundin K, and Schedel I: Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. J Immunol 1992;149:1452-1461.
54. Karpatkin S, Nardi MA, Liu LX, Kouri YH. and Borkowsky W: Production of a human anti-CD4 monoclonal antibody with anti idiotypic to anti-HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses 1995;11:509-515.
55. Bruck C, Co MS, Slaoui M, Gaulton GN, Smith T, Fields BN, Mullins JI, and Greene MI: Nucleic acid sequence of an internal image bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci USA 1986;83:6578-6582.
56. Taub R, Hsu JC, Garsky VM, Hill BL, Erlanger BF, and Kohn LD: Peptide sequence from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin TSH receptor are similar to TSH and inhibit TSH increased cAMP production in FRTL-5 thyroid cells. J Biol Chem 1992;267:5977-5984.
57. Weissenhorn W, Scheuer W, Kaluza B, Schwirzke M, Reiter C, Flieger D, Lenz H, Weiss EH, Rieber EP, Riethmuller G, and Weidle UH: Combinatorial effect of two chimeric antibodies directed to human CD4 and of one chimeric antibody directed to the a chain of the human interleukin-2 receptor. Gene 1992; 121:271-278.